These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4482742)

  • 1. [Plasmapheresis in donors].
    Rachinskaia NA
    Med Sestra; 1972 May; 31(5):23-6. PubMed ID: 4482742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiological study of hepatitis C virus (HCV) infection in plasmapheresis and blood donors].
    Jin ZL; Chen SQ; Shi ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):234-6. PubMed ID: 7585906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethics, motivations of plasmapheresis donors].
    Schneider T; Fontaine O; Huart JJ
    Transfus Clin Biol; 2004 Jul; 11(3):146-52. PubMed ID: 15488727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide serum concentration decreases in donors undergoing discontinuous plasmapheresis involving a large extracorporeal blood volume.
    Karger R; Halbe M; Giffhorn-Katz S; Katz N; Kretschmer V
    Transfusion; 2007 Sep; 47(9):1717-24. PubMed ID: 17725739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An epidemiological study on malaria infection in plasmapheresis donors].
    Chen SL; Zhang ZK; Zhao Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Nov; 28(6):350-2. PubMed ID: 7867454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C virus infection among the plasmapheresis donors].
    Wang S; Ding H; Zhang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):71-3. PubMed ID: 7522967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of immunoglobulins in blood donors during long-term intensive plasmapheresis.
    Smálik S; Mikula L; Stanislavová V
    Rev Czech Med; 1972; 18(2):77-85. PubMed ID: 5030717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peripheral blood indices in donors during plasmapheresis].
    Asmolov AI; Sheviakova IA; Bannikova TP; Petrikoveta NI
    Probl Gematol Pereliv Krovi; 1969 Aug; 14(8):57. PubMed ID: 5350615
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmapheresis in donors].
    Gutnik RB
    Probl Gematol Pereliv Krovi; 1967 Sep; 12(9):34-7. PubMed ID: 5620129
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of repeated plasmapheresis in blood donors.
    Daszyński J; Klenowska Z; Kotelba-Witkowska B; Lewicz I; Rodkiewicz H
    Pol Med J; 1968; 7(1):66-72. PubMed ID: 5650204
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the mechanism of natural immunity in blood donors subjected to repeated plasmapheresis].
    Jasser S; Daszyński J; Klenowska Z
    Pol Tyg Lek; 1968 May; 23(21):775-8. PubMed ID: 5667487
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The life span of erythrocytes reinfused to donors during plasmapheresis].
    Gutnik RB; Pinchuk LB
    Probl Gematol Pereliv Krovi; 1972 Jul; 17(7):22-4. PubMed ID: 4667309
    [No Abstract]   [Full Text] [Related]  

  • 17. [Application of repeated plasmapheresis in blood donors].
    Daszyński J; Klenowska Z; Kotelba-Witkowska B; Lewicz I; Rodkiewicz H
    Pol Tyg Lek; 1967 Apr; 22(14):514-6. PubMed ID: 6045885
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on natural immunity mechanisms in blood donors subjected to repeated plasmapheresis.
    Jasser S; Daszyński J; Klenowska Z
    Pol Med J; 1969; 8(2):330-5. PubMed ID: 5772792
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of multiple plasmapheresis on levels of apolipoprotein B, fibrinogen and cholesterol in blood donors].
    Kondera-Anasz Z; Grabińska M; Jochemczyk J; Mertas A; Słapa-Uznańska V
    Wiad Lek; 1995; 48(1-12):184-9. PubMed ID: 9638237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems in blood donors in plasmapheresis and cytopheresis].
    Fiala J
    Vnitr Lek; 1982 Feb; 28(2):182-8. PubMed ID: 7064373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.